satavaptan (SR121463B)

DRUG4 trials

Sponsors

Sanofi

Conditions

AscitesHyponatremiaLiver CirrhosisSyndrome of Inappropriate ADH (SIADH) Secretion

Phase 2

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

CompletedNCT00032734

SanofiHyponatremia, Syndrome of Inappropriate ADH (SIADH) Secretion

Start: 2001-06-30End: 2003-07-31Updated: 2008-06-17

Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites

CompletedNCT00501722

SanofiAscites, Liver Cirrhosis

Start: 2004-04-30End: 2005-03-31Updated: 2009-01-12

Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites

CompletedNCT00501566

SanofiAscites, Liver Cirrhosis

Start: 2004-04-30End: 2005-01-31Updated: 2007-07-16

Satavaptan Dose-Ranging Study in the Prevention of Ascites

CompletedNCT00501384

SanofiAscites, Liver Cirrhosis

Start: 2004-04-30End: 2005-05-31Updated: 2009-01-12